Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63967 | Target Info | |||
Target Name | Neuronal acetylcholine receptor alpha-4/beta-2 (CHRNA4/B2) | ||||
Synonyms |
CHRN; nAChR
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | CHRNA4-CHRNB2 | ||||
Biochemical Class | Neurotransmitter receptor | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Neuronal acetylcholine receptor alpha-3/beta-4 (CHRNA3/B4) | Successful Target | ||||
UniProt ID | ACHA3_HUMAN-ACHB4_HUMAN | |||||
Gene Name | CHRNA3-CHRNB4 | |||||
Synonyms |
Neuronal acetylcholine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Varenicline | Drug Info | Ki = 74.7 nM | Click to Show More | [1] | |
2 | Varenicline | Drug Info | Ki = 240 nM | [2] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-7 (CHRNA7) | Successful Target | ||||
UniProt ID | ACHA7_HUMAN | |||||
Gene Name | CHRNA7 | |||||
Synonyms |
Nicotinic acetylcholine receptor subunit alpha 7; Nicotinic acetylcholine receptor alpha7; CHRNA7; Alpha7 nicotinic receptor; Alpha7 nAChR; Alpha-7 nAChR; Alpha(7) nicotinic receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Varenicline | Drug Info | Ki = 125 nM | [1] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha4/beta4 (CHRNA4/CHRNB4) | Co-Target | ||||
UniProt ID | ACHA4_HUMAN; ACHB4_HUMAN | |||||
Gene Name | CHRNA4; CHRNB4 | |||||
Representative Drug(s) | Varenicline | Drug Info | Ki = 110 nM | [3] | ||
Co-Target Name | Acetylcholine receptor alpha-1/beta-1/delta/gamma (CHRNA1/CHRNA1/CHRND/CHRNG) | Co-Target | ||||
UniProt ID | ACHA_HUMAN-ACHB_HUMAN-ACHD_HUMAN-ACHG_HUMAN | |||||
Gene Name | CHRNA1-CHRNB1-CHRND-CHRNG | |||||
Representative Drug(s) | Varenicline | Drug Info | EC50 ~ 1000 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4749-52. | ||||
REF 2 | Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005 May 19;48(10):3474-7. | ||||
REF 3 | Discovery of highly potent and selective alpha4beta2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. J Med Chem. 2012 Nov 26;55(22):9998-10009. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.